Kenvue Inc. (KVUE) es una empresa que cotiza en bolsa en el Consumo Defensivo sector, operando dentro de la Household & Personal Products industria. La empresa tiene su sede en Summit, NJ, United States. El CEO actual es Kirk L. Perry.
KVUE tiene fecha de IPO 2023-05-04, 22,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $33.31B.
Kenvue Inc. is a global consumer health company offering a diverse portfolio of over-the-counter medications and personal care products across three main segments. The Self Care segment includes pain relief, cold and allergy remedies, digestive health, and smoking cessation products marketed under brands such as Tylenol, Zyrtec, and Nicorette. The Skin Health and Beauty segment provides facial, body, and hair care products under the Neutrogena, Aveeno, and OGX brands, while the Essential Health segment offers oral care, baby care, women's health, and wound care solutions through brands including Listerine, Johnson's, Band-Aid, and Stayfree. Incorporated in 2022 and headquartered in Skillman, New Jersey, Kenvue operates as a subsidiary of Johnson & Johnson.
